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The budded virus (BV) of the Autographa californica multicapsid nucleopolyhedrovirus (AcMNPV) infects
insect cells and transduces mammalian cells mainly through the endocytosis pathway. However, this study
revealed that the treatment of the virus bound to Sf9 cells at low pH could efficiently rescue the infectivity of
AcMNPV in the presence of endocytosis pathway inhibitors. A colocalization assay of the major capsid protein
VP39 with the early endosome marker EEA1 showed that at low pH, AcMNPV entered Sf9 cells via an
endosome-independent pathway. Using a fluorescent probe (R18), we showed that at low pH, the viral
nucleocapsid entered Sf9 cells via direct fusion at the cell surface. By using the myosin-specific inhibitor
2,3-butanedione monoxime (BDM) and the microtubule inhibitor nocodazole, the low pH-triggered direct
fusion was demonstrated to be dependent on myosin-like proteins and independent of microtubules. The
reverse transcription-PCR of the IE1 gene as a marker for viral entry showed that the kinetics of AcMNPV in
cells triggered by low pH was similar to that of the normal entry via endocytosis. The low pH-mediated infection
assay and VP39 and EEA1 colocalization assay also demonstrated that AcMNPV could efficiently transduce
mammalian cells via direct membrane fusion at the cell surface. More importantly, we found that a low-pH
trigger could significantly improve the transduction efficiency of AcMNPV in mammalian cells, leading to the
potential application of this method when using baculovirus as a vector for heterologous gene expression and
for gene therapy.
Enveloped viruses infect host cells by attaching to the cell
surface and delivering their genetic material into the cyto-
plasm. One of the most crucial steps in this process is the
fusion event between the viral envelope and a cellular mem-
brane, which allows the passage of nucleocapsids through the
cellular membrane into the cytoplasm. The fusion event could
occur at the cell surface or with particular cellular vesicles,
such as endosomes. Human immunodeficiency virus type 1
(HIV-1) and rotaviruses fuse at the cell surface (18, 26, 31)
while other viruses, including influenza virus, Ebola virus, and
vesicular stomatitis virus, take the endocytosis entry pathway
and fuse with the endosome membrane (22, 40–41). Some
viruses can utilize different ways to enter different cells. For
example, Semliki Forest virus (SFV) is internalized into the
endosomes when infecting CHO cells, while the virus infects
BHK-21 cells by fusing with the cell membrane (12, 27, 51).
Influenza virus normally infects cells via the endocytosis path-
way (22, 29, 39), yet some researchers have demonstrated that
it infects HeLa cells in the absence of clathrin-mediated en-
docytosis (37). Herpes simplex virus (HSV) infects Vero cells
by fusion with the cell surface, while it enters HeLa and
CHO-K1 cells through the endocytosis pathway (32).
Baculoviruses belong to the Baculoviridae, a family of rod-
shaped enveloped viruses. There are two distinct virion phe-
notypes: occlusion-derived virus (ODV) and budded virus
(BV). ODV infects the midgut cells of the insects and initiates
primary infection, while BV infects the other tissues of the insect
and is responsible for secondary or systemic infection (46). ODV
enters the cell by direct membrane fusion between the ODV
envelope and brush border membrane vesicles (BBMV) or host
cell membrane (9, 15). It generally is believed that the clathrin-
dependent endocytosis pathway is taken as the major pathway to
infect the cells by BV, and it is a pH-dependent pathway (2, 24,
44). This conclusion was confirmed by the observation of virus
particles in coated pits under the electron microscope (42). Entry
by a clathrin-mediated endocytosis also was confirmed by the
inhibition effects of chlorpromazine (CPZ) (25), which interfered
with the infection of the virus by preventing the formation of the
clathrin-coated vesicles (47), and ammonium chloride (NH4Cl),
which prevented the infection of the virus by elevating the pH of
the late endosomes (11, 44). However, researchers have revealed
that the BV of Trichoplusia ni NPV (TnNPV) penetrated the
cytoplasm directly from the cell surface (21, 50). For AcMNPV in
the genus Alphabaculovirus, immunoelectron microscopy studies
also revealed that some viruses entered the cells by fusing with the
cell membranes under certain conditions, but this alternate entry
pathway was not considered efficient because it was believed that
this pathway would lead to genomic degradation (45).
Baculoviruses have been used extensively for the expression
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of recombinant proteins both in insect and mammalian cells
(16, 20, 33). AcMNPV also has been successfully transduced
into mammalian cells for gene expression and shows great
potential for becoming a gene therapy vector (4, 14, 19, 36, 43).
It has been well documented that baculoviruses utilize the
clathrin-mediated endocytosis pathway to enter mammalian
cells as it does in insect cells (25, 28, 42). One of the most
important early events of a successful transduction is the bind-
ing of the virus to the receptor on the mammalian cells. Al-
though the receptor on mammalian cells has not been identi-
fied, it is possible that electrostatic interactions between
heparin sulfate and the major envelope protein GP64 are in-
volved in this process (2, 5, 11). AcMNPV is absorbed into the
endosomes, and the virus envelope is proposed to fuse with the
endosome membrane with the help of GP64. After being re-
leased from the endosome, the nucleocapsids presumably
travel through the nuclear pores to complete the transduction
process (42).
Some envelope viruses, which enter cells mainly through the
pH-dependent pathway, can be forced to fuse with the cell
membranes by culturing the cell-bound viruses under low pH
(27). The direct fusion between the virus envelope and the cell
membrane also was observed after AcMNPV-bound cells were
triggered under acidic conditions, even in the presence of so-
dium azide, which inhibited endocytosis (49). However, the
consequence of direct fusion and whether it results in efficient
infection is unknown. In this study, we explored whether low
pH can cause the direct fusion of AcMNPV to host cell mem-
branes for successful infection/transduction, especially in the
presence of endocytosis inhibitors. We determined that a
short-term exposure to low pH allowed AcMNPV to bypass
the endocytosis pathway to gain entry into insect cells. We also
investigated the involvement of cytoskeleton molecules and the
entry kinetics of AcMNPV infection at low pH. Interestingly,
in mammalian cells, the low-pH treatment not only allowed the
virus to bypass endocytosis-mediated entry but also dramati-
cally improved the AcMNPV transduction rate. This suggests
that low-pH treatment is a very useful method when using
baculovirus as a vector for gene expression in mammalian cells
and for gene therapy.
MATERIALS AND METHODS
Cells and viruses. Spodoptera frugiperda Sf9 cells were propagated at 28°C in
Grace’s insect medium (Gibco-BRL) supplemented with 10% fetal bovine serum
(FBS, Gibco-BRL), pH 6.0. The mammalian HepG2 and HeLa cell lines were
cultured in Dulbecco’s modified Eagle medium (DMEM; Gibco-BRL) supple-
mented with 10% fetal bovine serum (FBS), pH 7.0. The AcMNPV bacmid was
the commercially available bacmid bMON14272 (Invitrogen) and was propa-
gated in Escherichia coli strain DH10B.
Construction of vAc-EGFP and vAc-CMV-EGFP. The recombinant AcMNPV
with the enhanced green fluorescent protein (egfp) reporter gene, vAc-EGFP
and vAc-CMV-EGFP (Fig. 1), were generated according to the manufacturer’s
instructions for the Bac-to-Bac baculovirus expression system (Gibco-BRL). To
generate the donor plasmid pFastBacDual-EGFP, the EGFP cassette was di-
gested from the pEGFP-N1 plasmid (Clontech) as an NcoI-NotI fragment,
blunted, and subcloned downstream of the p10 promoter of the transfer vector
pFastBacDual (Gibco-BRL), which was blunted after being digested with SmaI
and NcoI. To construct the donor plasmid pFastBacHTb-CMV-EGFP, the
Orgyia pseudotsugata MNPV (OpMNPV) gp64 promoter (Op166) was cut from
the plasmid pFB-Op166 (48) with BamHI and inserted into pEGFP-N1 to
generate the plasmid pEGFP-N1-Op166. Subsequently, pEGFP-N1-Op166 was
digested with NheI and SmaI to remove the residual multiple cloning sites and
self ligated. The CMV-Op166-EGFP-SV40 poly(A) cassette then was digested
from this plasmid by AseI and AflII, blunted, and ligated into the blunted
EcoRI site of the vector pFastBacHTb (Gibco-BRL). Each of the donor
plasmids (pFastBacDual-EGFP and pFastBacHTb-CMV-EGFP) was trans-
formed into competent DH10Bac cells containing the AcMNPV bacmid and
the helper plasmid expressing the transposase (Gibco-BRL). The transposi-
tion of inserts from donor plasmids to the AcMNPV bacmid was confirmed by
diagnostic PCR. The identified bacmids were named Ac-EGFP and Ac-CMV-
EGFP. Each purified bacmid DNA (1 g) was transfected into Sf9 cells
cultured in 35-mm-diameter tissue culture dishes at 1  106 cells per dish
using 12 l Lipofectin reagent according to the Bac-to-Bac expression system
manual (Gibco-BRL). Supernatants were collected at 3 days posttransfection
(p.t.) and used to infect Sf9 cells for viral amplification. The viruses were
designated vAc-EGFP and vAc-CMV-EGFP, and the titers (50% tissue cul-
ture infectious doses [TCID50], in units/milliliter) were determined by end-
point dilution assays (EPDA) on Sf9 cells.
Infection of Sf9 cells under low pH and with inhibitors of the endocytosis
pathway. In this study, NH4Cl or CPZ was used separately to inhibit the endo-
cytosis pathway of Sf9 cells. The cells infected without chemical treatment under
normal pH were set up as the control. The 24-well tissue culture plates were
seeded prior to infection at a density of 2 105 cells per well and pretreated with
Grace’s medium containing either 25 mM NH4Cl (Beijing YILI Fine Chemical
Co., Ltd.) or 20 g/ml CPZ (Sigma) at 28°C for 40 min and chilled to 4°C for an
additional 20 min. Subsequently, the cells were incubated with vAc-EGFP at a
multiplicity of infection (MOI) of 1 TCID50 U/cell in the inhibitor-containing
medium at 4°C for 1 h. After the incubation, supernatants containing viruses
were removed, and the cells were incubated with acidic Grace’s medium, pH 4.8,
or normal Grace’s medium, pH 6.0, in the presence of the inhibitor at 28°C for
5 min. Subsequently, the medium was removed and the cells were further incu-
bated with fresh medium plus inhibitors at 28°C for 4 h. After being washed twice
with fresh Grace’s medium, the cells were cultured with normal Grace’s insect
medium supplemented with 10% FBS for 44 h before being harvested for flow-
cytometric analysis. The experiments were repeated three times, and standard
deviations were calculated by Microsoft Excel 2003.
Visualization of virus entry and membrane fusion. Fusion events of the virus
envelopes with the Sf9 cell membranes were determined by using octadecyl
rhodamine B chloride (R18)-labeled viruses under a fluorescence microscope.
Purified AcMNPV was labeled with the R18 probe (Invitrogen) as described by
Wang et al. (49), with slight modifications. Briefly, 100 l of 10 mg/ml R18 was
added to 50 ml of virus stock at a titer of 5  107 TCID50/ml. The mixture was
incubated for 60 min at room temperature, and the R18-labeled viruses were
separated from free probes by centrifugation at 42,900 g for 1 h at 4°C. Sf9 cells
were incubated and infected with R18-labeled virus as described above, and the
fluorescence was observed 60 min after infection.
Low pH-mediated infection of Sf9 cells with inhibitors of cytoskeleton mole-
cules. Nocodazole and 2,3-butanedione monoxime (BDM) were used to inhibit
the function of microtubules and myosin-like proteins, respectively, during in-
fection triggered by low pH. The cells infected without chemical treatment under
normal pH were set up as the control. The 24-well tissue culture plates were
seeded in advance with a density of 2  105 cells per well and pretreated with
Grace’s medium containing either 20 M nocodazole (Sigma) or 10 mM BDM
FIG. 1. Construction of recombinant baculoviruses. The reporter
gene egfp is under the control of the P10 and CMV IE1/Op166 pro-
moters in vAc-EGFP and vAc-CMV-EGFP, respectively.
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(Sigma) at 28°C for 40 min and chilled to 4°C for an additional 20 min. The rest
of the experiments were the same as those described above for the NH4Cl and
CPZ inhibition experiments, except that in the control samples for BDM and
nocodazole treatment, 1% methanol or dimethylsulfoxide (DMSO), instead of
the chemicals, was added to the cells, respectively. Additionally, in the BDM
inhibition assay, the BDM was maintained in Grace’s medium until the flow-
cytometric analysis. The experiments were repeated three times, and standard
deviations were calculated. The inhibition rates of the nocodazole treatments
with the control were analyzed with the Wilcoxon W test.
Comparison of viral entry kinetics of normal infection to those of low pH-
mediated infection when endocytosis was inhibited. The kinetics of viral entry in
Sf9 cells were determined by reverse transcription-PCR (RT-PCR) based on the
transcription of the IE1 gene. Sf9 cells (1  106) cultured in 35-mm-diameter
tissue culture dishes were preincubated at 28°C for 40 min in the presence or
absence of 25 mM NH4Cl. vAc-EGFP at an MOI of 1 was added in NH4Cl-
containing medium or normal medium and incubated at 4°C for 1 h. Subse-
quently, the supernatants were removed and marked as 0 min. The cells were
treated with acidic (pH 4.8) or normal (pH 6.0) Grace’s medium for 5 min at
28°C and then cultured with normal Grace’s insect medium containing 10% FBS.
In the low pH-triggered sample, NH4Cl was present during the whole procedure.
The total RNA was isolated with TRIzol (Invitrogen) according to the manu-
facturer’s instructions at 0, 30, 60, 90, and 120 min after the binding procedure
and then was treated with RQ1 RNase-Free DNase (Promega) to prevent DNA
interference with the subsequent RT-PCRs. RT-PCR was performed using 1 g
of treated total RNA per time point as the template. The synthesis of the
first-strand cDNA was performed using M-MLV Reverse Transcriptase (Pro-
mega) and oligo(dT) primers (5-CTGATCTAGAGGTACCGGATCCTTTTT
TTTTTTTTTT-3) according to the manufacturer’s instructions. The PCR am-
plification of cDNA was performed using the IE1-specific primers IE1-F (5-A
AATACAGCAGCGTCGCTAATC-3) and IE1-R (5-CGTCGGACAACGGA
ACCAGA-3).
Low pH-mediated transduction of vAc-CMV-EGFP in mammalian cells. Cells
transduced without chemical treatment under normal pH were set up as the
control. HepG2 or HeLa cells were preincubated at 37°C for 30 min in the
presence of 10 or 25 mM NH4Cl, respectively. The cells were incubated for an
additional 15 min at 4°C and subsequently transduced with vAc-CMV-EGFP at
MOIs of 50 and 10. The cells were incubated at 4°C with NH4Cl for 1 h to allow
the viruses to bind the cells. After the binding period, the medium was replaced
with phosphate-buffered saline (PBS) at pH 4.8 in the presence of NH4Cl at
room temperature for 5 min. The PBS was removed and fresh medium with
NH4Cl was added, and the cells were incubated at 37°C for an additional 2 h. The
medium was removed, and the cells were washed twice. The fresh DMEM
supplemented with 10% FCS was added, and the cells were incubated at 37°C for
another 24 h before being harvested for flow-cytometric analysis. Standard de-
viations were calculated based on three replicates.
Immunofluorescence microscopy. HepG2 or Sf9 cells, grown in a 35-mm dish
containing glass coverslips, were transduced or infected with vAc-CMV-EGFP
(MOI  50) or vAc-EGFP (MOI  10) as described above. Thirty-five or 60 min
after vAc-CMV-EGFP was added to the HepG2 cells, or 20 min after vAc-EGFP
was added to Sf9 cells, the cells were washed twice with PBS and fixed with 96%
ethanol for 15 min at room temperature. The fixed cells were washed three times
with PBS and blocked with PBS containing 5% BSA for 60 min at 37°C. After
that the cells were washed three times with PBS and incubated for 90 min in PBS
containing anti-VP39 protein antiserum (1:500; kindly provided by Kai Yang,
Sun-Yat Sen University, China) at 37°C. The cells were washed three times with
PBS, followed by incubation for 90 min at 37°C in PBS containing rhodamine-
conjugated goat anti-rabbit IgG (1:150; Millipore). Cells were washed three
times with PBS and incubated with fluorescein isothiocyanate (FITC) mouse
anti-human EEA1 (1:200; BD Transduction Laboratories) at 37°C for 90 min.
After three washes with PBS, the cell nuclei were stained with Hoechst 33258 for
5 min at room temperature. Finally, the cells were mounted onto slides for
capturing images with a fluorescence microscope.
RESULTS
Low pH efficiently triggers AcMNPV infection in Sf9 cells
even when the endocytosis pathway is blocked. To test whether
AcMNPV BV could infect Sf9 cells at low pH, we provided an
acidic external pH environment in the presence or absence of
the endocytosis inhibitors. Two chemicals were used as endo-
cytosis inhibitors in our study: NH4Cl, which blocks membrane
fusion in the endosomes, and CPZ, which prevents the assem-
bly of clathrin-coated pits. Sf9 cells were pretreated with
NH4Cl or CPZ and then incubated with vAc-EGFP in the
presence of the chemicals for the duration of the infection.
Cells were observed under a fluorescent microscope for the
presence of green fluorescence at 48 h postinfection (p.i.), and
the infection rate was analyzed by flow cytometry. The infec-
tion rate of the controls (normal infection without the treat-
ments of the chemicals and low pH) were set as 100%. When
virus-bound cells were treated with acidic medium in the ab-
sence of the chemicals at 28°C for 5 min, the proportions of
infected cells were similar to those of the controls (Fig. 2). As
predicted, treatment of cells with NH4Cl and CPZ almost
completely blocked the infection. The infection rate was only 8
and 18% for NH4Cl- and CPZ-treated viruses, respectively,
compared to results for the control (Fig. 2). When the virus-
bound cells were exposed to the acidic medium in the presence
of NH4Cl or CPZ at 28°C for 5 min, vAc-EGFP could effi-
ciently infect cells at a level of 114 and 85%, respectively, which
is similar to that of normal infection (Fig. 2). Combined with
the results of the NH4Cl and CPZ inhibition assay, these re-
sults suggested that the acidic environment triggered the fusion
process at the cell membrane that led to the effective infection
of the virus-bound Sf9 cells, even in the presence of the endo-
cytosis pathway inhibitors.
AcMNPV induced to enter Sf9 cells by low pH does not
colocalize with the early endosome marker EEA1. The early
endosome marker EEA1 (28) was used to further check
whether viruses entered Sf9 cells through the endocytosis-
FIG. 2. Low pH-triggered infection assay in Sf9 cells with inhibitors
of the endocytosis pathway. Normal infection without chemical treat-
ment and low-pH treatment was set as the control. vAc-EGFP (MOI
1) was allowed to bind to Sf9 cells at 4°C for 60 min, and then the
unbound viruses were washed away and the pH was shifted to 4.8 for
5 min. The endocytosis pathway was blocked with NH4Cl or CPZ.
(A) Flow-cytometric analysis of the infection assay in Sf9 cells at 48 h
p.i. The white or shaded control columns represent cells infected at
normal pH from the CPZ or NH4Cl series of experiments, respectively,
but that were not treated with CPZ or NH4Cl, respectively. The error
bars represent standard deviations. (B) Fluorescence images of the
infected cells at 48 h p.i. The upper images show the infected cells with
NH4Cl. The lower images show the infected cells with CPZ.
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dependent or -independent pathway induced by acid condi-
tions. The viruses that entered the cells under normal condi-
tions were used as the controls. Twenty minutes after vAc-
EGFP was added, the cells were fixed for observation. In the
control sample, VP39, as detected by anti-VP39 immunofluo-
rescence, was shown to colocalize with EEA1 in the Sf9 cells at
20 min p.i. (Fig. 3A), which is consistent with the knowledge
that baculoviruses normally enter the cells via endocytosis. The
same colocalization was observed in the cells pretreated with
NH4Cl (Fig. 3C), indicating that when NH4Cl blocked fusion
at the endosome, the viruses remained in the endosomes.
However, when the virus-bound cells were treated with the
external acid environment, the capsid protein VP39 was de-
tected in the cells but failed to colocalize with EEA1 (Fig. 3B).
In the cells pretreated with NH4Cl and treated with the acidic
medium, the capsid protein VP39 also was found at the cell
periphery but failed to colocalize with EEA1 (Fig. 3D). These
observations revealed that the external acidic treatment of the
virus-bound cells allowed the virus to enter the Sf9 cells
through a nonendocytic pathway. Therefore, this modification
of the entry pathway led to the recovery of virus infectivity in
the NH4Cl/CPZ inhibition assay.
Under low-pH conditions, AcMNPV entered the Sf9 cells via
direct fusion of the virion envelope with the cell membrane.
The experiments described above have shown that under
low-pH conditions, AcMNPV entered the Sf9 cells via an en-
docytosis-independent pathway. In this experiment, the R18
probe was used to visualize whether the viruses entered the
cells by direct membrane fusion at the cell surface. R18 is a
fluorescent membrane probe inserted into the virus envelope
that allows the location of the virus envelope to be tracked.
AcMNPV were labeled with the R18 probe and used to infect
Sf9 cells as described in Materials and Methods. Sf9 cells in-
fected with viruses under the normal conditions were set as the
control, and no obvious fluorescence was detected on the plasma
membranes (Fig. 4A). In the NH4Cl-treated cells, fluorescence
could not be observed on the plasma membranes either (Fig. 4C).
However, when the virus-bound cells were treated under low-pH
conditions, fluorescence could be observed on the plasma mem-
branes with or without NH4Cl treatment (Fig. 4B, D). These
results were consistent with a former report (49) and indicated
that AcMNPV entered the cells via direct fusion at the cell sur-
face induced by the acidic environment.
With low pH-induced viral entry, the transport of nucleo-
capsids to the nucleus is myosin-like protein dependent and
microtubule independent. It has been demonstrated that the
release of the BV nucleocapsids from endosomes into the cy-
toplasm induces the formation of the actin filaments, and the
myosin-like proteins are involved in nucleocapsid transport to
the nucleus (23). To investigate whether myosin-like proteins
are involved in the infection process mediated by the direct
fusion at the cell surface, Sf9 cells were infected in the pres-
ence of BDM for the low-pH treatment experiments as
described in Materials and Methods, and the numbers of
EGFP-positive cells in each condition were compared by flow-
cytometric analysis. BDM inhibits myosin by blocking the re-
lease of phosphorylated protein after ATP hydrolysis (13). The
infection rate of the control sample, which was not treated with
BDM, was set as 100%. As shown in Fig. 5, in the presence of
BDM, the infection rate of vAc-EGFP was greatly reduced in
either low pH-treated cells (28%) or untreated cells (28%).
These results implied that the myosin-like proteins play an
important role in the transport of the nucleocapsids toward the
FIG. 3. Colocalization (yellow) of the vAc-EGFP (MOI  10) cap-
sid protein VP39 (red) with the early endosome marker EEA1 (green)
at 20 min p.i. in Sf9 cells. EEA1 was conjugated with FITC while VP39
was detected with rhodamine-tagged goat anti-rabbit antibodies. Sf9
cells infected with neither NH4Cl nor low-pH treatment were set up as
the control sample. (A) In the control sample, VP39 colocalized with
EEA1 (arrows). (B) In the low pH-treated sample, VP39 failed to
colocalize with EEA1. (C) In the NH4Cl-treated sample, VP39 colo-
calized with EEA1 (arrows). (D) In the low pH- and NH4Cl-treated
sample, VP39 also failed to colocalize with EEA1. Bars, 5 m.
FIG. 4. Visualization of virus entry and membrane fusion. R18-
labeled vAc-EGFP (MOI  10) was allowed to bind to Sf9 cells at 4°C
for 60 min. Unbound viruses then were washed away and the cells were
treated at low pH (B, D) or left untreated (A, C). Membrane fusion
between virus envelopes and cell membranes was observed by fluores-
cence microscopy at 60 min after infection. The endocytosis pathway
was blocked with NH4Cl (C, D).
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nucleus following the direct fusion at the cell surface as well as
in the classic endocytosis pathway.
Microtubules are utilized by many viruses for transporting
the nucleocapsids in the cytoplasm; however, they are not
considered to be involved in the transport of baculovirus nu-
cleocapsids following endocytosis (35, 42). We examined the
role of the microtubule cytoskeleton in nucleocapsid transport
after fusion at the cell surface. Nocodazole, a specific agent
that depolymerizes microtubules, was added to the cells. The
infection assay was performed as described in Materials and
Methods. The infection rate of vAc-EGFP in the absence of
nocodazole was set as 100%. Compared to results for the
control sample, nocodazole showed no obvious effects on the
infection rate of the viruses (87%; P  0.05) entering through
the endocytosis pathway. In the sample treated under low pH,
nocodazole also had no obvious inhibitory effect on the infec-
tion rate (90%; P  0.05) (Fig. 5). These data suggest that
intact microtubules are not involved in the process of nucleo-
capsid transport in either the endocytosis or the direct fusion
entry pathways.
AcMNPV entered Sf9 cells through the endocytosis pathway
and direct fusion pathways at similar rates. The speed of entry
is an important characteristic of a particular infection pathway,
and it may differ between different infection pathways. It has
been demonstrated that severe acute respiratory syndrome
coronavirus (SARS-CoV) entering via the cell surface repli-
cates 1 h ahead of the virus entering through the endocytosis
pathway (30). To further define the entry kinetics of AcMNPV
into Sf9 cells through different entry pathways, the IE1 gene
was chosen in our study as the marker gene, because it is an
immediate-early gene with transcription that is initiated as
soon as the virus enters the nucleus (10). The transcription of
IE1 was detected by RT-PCR. IE1-specific primers were used
to detect the IE1 gene expression after DNase I digestion to
eliminate DNA contamination. In infections under both nor-
mal conditions and low pH with blocked endocytosis condi-
tions, IE1 transcription was detected as early as 60 min after
infection (Fig. 6). As the synthesis of IE1 mRNA was consid-
ered the indicator of virus entry into the nucleus, this obser-
vation suggested that the viruses utilizing these two distinct
entry pathways penetrated the cytoplasm and were transported
to the nucleus at nearly the same speed. The infectious BV
production of AcMNPV entry via the direct fusion pathway or
the endocytosis pathway was analyzed by an endpoint dilution
assay (EPDA). Results show that AcMNPV infection in Sf9
cells via two entry pathways has similar dynamics of BV pro-
duction (data not shown).
The external acidic environment significantly increased
the rate of the AcMNPV transduction of mammalian cells.
AcMNPV can transduce several mammalian cell types, includ-
ing HepG2 and HeLa cells, and it is considered a potential
gene therapy vector (14, 19). However, AcMNPV has some
shortcomings as a gene transduction vector, including a rela-
tively low transduction rate compared to that of other systems.
Only about 30% of cells can be transduced with viruses at an
MOI of up to 100 at 4°C (28). Although some researchers have
increased the transduction rate in certain mammalian cells by
several surface-modified baculoviruses (1, 7, 8, 17, 34), further
improvements are required. Considering that the virus fused at
the cell surface can successfully infect the insect cells as well as
when entering through the endocytosis pathway, we wondered
whether the modification of the infection pathway for mam-
malian cells could increase the transduction rate.
In this study, HepG2 and HeLa were transduced as de-
scribed in Materials and Methods. For all four controls, the
percentage of transduced cells was less than 10%. On HepG2
cells, when the virus-bound cells were treated with acidic PBS,
the proportion of the transduced cells showed a significant
increase of up to 21.6% (MOI  10) and 58.0% (MOI  50)
compared to levels of the control transduced cells. The acidic
PBS treatment of the virus-bound cells also increased the pro-
portion of the transduced cells even in the presence of NH4Cl.
To our surprise, the combined use of NH4Cl and acidic PBS
FIG. 5. Low pH-mediated infection of Sf9 cells with inhibitors of
cytoskeleton molecules. Normal infection without the chemical treat-
ment and low-pH treatment was set as the control. vAc-EGFP (MOI
1) was allowed to bind to Sf9 cells at 4°C for 60 min. The unbound
viruses then were washed away, and the pH was shifted to 4.8 for 5 min.
The functions of microtubules and myosin-like proteins were blocked
with nocodazole (gray bar) and BDM (white bar), respectively.
(A) Flow-cytometric analysis of the infection rate of Sf9 cells at 48 h
p.i. The white or shaded control columns represent cells infected at
normal pH from the BDM or nocodazole series of experiments, re-
spectively, but that were not treated with BDM or nocodazole, respec-
tively. The error bars represent standard deviations. (B) Fluorescence
images of the infected cells at 48 h p.i. The upper images show the
infected cells with nocodazole. The lower images show the infected
cells with BDM.
FIG. 6. Time course analysis of IE1 transcription in Sf9 cells in-
fected by vAc-EGFP (MOI  1) through the endocytosis or direct
fusion pathway. The cell samples were collected at 0, 30, 60, 90, and
120 min p.i., and total RNA was extracted for the RT-PCR analysis of
IE1 expression. P, positive control; N, template minus control; Mock,
uninfected Sf9 cells.
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increased the proportion of the transduced cells to a much
higher level than that observed with acidic PBS alone, up to
44.2% (MOI  10) and 78.5% (MOI  50). When the same
experiment was carried out on HeLa cells, the acidic PBS
treatment of the virus-bound cells also improved the transduc-
tion rate significantly, up to 35.6% (MOI  10) and 73.9%
(MOI  50). After incubation with NH4Cl, the acid treatment
again increased the transduction rate. The proportions of
transduced cells were 42.3% (MOI  10) and 72.5% (MOI 
50) (Fig. 7). In these experiments, the acid treatment of the
virus-bound mammalian cells showed an ability to dramatically
increase the proportion of the transduced cells, and the com-
bined use of the endocytosis inhibitor NH4Cl with acidic treat-
ment could increase the transduction rate more significantly
than the use of the acid trigger alone, at least on HepG2 cells.
These results indicated that the presumptive artificial shift of
the entry pathway increased the transduction rate in certain
mammalian cells.
AcMNPV entering HepG2 cells with a low-pH trigger did
not colocalize with the early endosome marker EEA1. It is well
established that AcMNPV enters mammalian cells mainly
through the endocytosis pathway, and the major capsid protein
VP39 colocalizes with the early endosome marker EEA1 (28).
Therefore, in our study, we investigated the viral entry pathway
after the acidic treatment of the virus-bound cells by observing
the localization of VP39 and EEA1 by immunofluorescence
microscopy. The virus entering the cells through the endocy-
tosis pathway was set as the control. In the control sample,
VP39 was shown to colocalize with EEA1 in HepG2 cells at 35
min and 60 min p.t. (Fig. 8A, A). This observation was con-
sistent with results shown in Fig. 3 and a previous report (28).
The same colocalization was observed in the cells pretreated
with NH4Cl (Fig. 8C, C). When the virus-bound cells were
treated with an external acidic environment, VP39 could enter
the cells but failed to colocalize with EEA1 (Fig. 8B, B). In the
cells pretreated with NH4Cl, the acid trigger also showed that
VP39 and EEA1 did not colocalize (Fig. 8D, D). These ob-
servations suggested that the significant increase of the trans-
duction rate on the acid treatment of the virus-bound mam-
malian cells was due to the virus entering via the cell surface
instead of through the endocytosis pathway.
DISCUSSION
In this report, we demonstrated that low-pH conditions can
induce BV of AcMNPV to enter Sf9 cells by direct fusion with
FIG. 7. Low pH-mediated transduction of mammalian cells by vAc-
CMV-EGFP. Normal transduction without the chemical treatment
and low-pH treatment was set as the control. vAc-CMV-EGFP
(MOI 10 or 50) was allowed to bind to HeLa and HepG2 cells at 4°C
for 60 min. The unbound viruses then were washed away, and the pH
was shifted to 4.8 for 5 min. The endocytosis pathway was blocked with
NH4Cl. (A) Flow-cytometric analysis of the transduction rate of mam-
malian cells at 24 h p.t. The error bars represent standard deviations.
(B) Fluorescence images of the transduced cells with virus at MOI 
50 at 24 h p.t. The upper images show the transduced HeLa cells. The
lower images show transduced HepG2 cells.
FIG. 8. Colocalization (yellow) of the vAc-CMV-EGFP (MOI  50) capsid protein VP39 (red) with the early endosome marker EEA1 (green)
at 35 or 60 min p.t. in HepG2 cells. EEA1 was conjugated with FITC, while VP39 was detected with rhodamine-tagged goat-anti rabbit antibodies.
HepG2 cells transduced with neither NH4Cl nor low-pH treatment was set up as the control sample. (A, A) In the control sample, VP39
colocalized with EEA1 (arrows). (B, B) In the low-pH sample, VP39 failed to colocalize with EEA1. (C, C) In the NH4Cl-treated sample, VP39
colocalized with EEA1 (arrows). (D, D) In the low pH- and NH4Cl-treated sample, VP39 also failed to colocalize with EEA1. Bar, 10 m.
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the cell surface. This conclusion was supported by the follow-
ing experiments. At normal pH, BV infection in Sf9 cells was
sensitive to NH4Cl and CPZ. This is consistent with the former
reports that demonstrate that the clathrin-dependent endocy-
tosis pathway is the major productive infection pathway (25,
28). However, the infectivity of the virus was recovered when the
virus-bound cells were triggered by the acidic environment for a
short time even in the presence of the endocytosis inhibitors (Fig.
2), suggesting that the acidic trigger forced AcMNPV to enter the
Sf9 cells through an endocytosis-independent pathway. Immuno-
fluorescent analysis showed that with low pH-induced entry, virus
nucleocapsid remains at the cell periphery and did not colocalize
with the early endosome marker EEA1, further confirming that
virus did not enter via the endocytosis pathway. The R18-labeled
membrane fusion assay further demonstrated that BV entered
Sf9 cells via direct membrane fusion at the cell surface (Fig. 4).
Taken together, these results illustrated well that the acidic envi-
ronment could cause BV of AcMNPV to fuse with the cell surface
and productively infect the cells. Furthermore, since ODV of
AcMNPV (9) and Lymantria dispar NPV (LdNPV) (15) were
demonstrated to enter insect cells via the direct fusion of ODV
envelop with the host cell membrane, the direct membrane fusion
pathway is suggested as being an important pathway for baculo-
virus nucleocapsid entry.
In addition, by using BDM and nocodazole, it was demon-
strated that the infection via direct membrane fusion induced
by low pH was myosin-like protein dependent and microtubule
independent (Fig. 5). By integrating previous studies with our
current observations, we generated a schematic representation
of entry pathways of AcMNPV BV (Fig. 9). In this model, BV
can enter and infect Sf9 cells through a clathrin-mediated
endocytosis pathway during normal infection or a direct fusion
pathway at the cell surface induced by low pH. In the clathrin-
mediated endocytosis pathway, the virus is sorted into the
clathrin-coated vesicles and then transported into the early
endosomes and late endosomes. After fusion with the endo-
somes, the virions are released and transported into the nu-
cleus with the help of actin and myosin-like proteins (23). In
the direct fusion pathway, virus fused with the cell membrane
under low pH and entered the cytoplasm. A most reasonable
speculation of this process is that after viruses bind to the cell
surface, external low pH induces the conformation change of
GP64, which leads to the exposure and insertion of the fusion
peptide into the plasma membrane and finally results in the
fusion and release of the nucleocapsids. Considering the sen-
sitivity to BDM, the inhibitor of the myosin-like proteins,
which was consistent with the virus entering through the en-
docytosis pathway (Fig. 4), it was most likely that the virus
utilized the same mechanism to transport their nucleocapsids
into the nucleus (Fig. 9).
Previously, by analyzing the residual infectivity of AcV1 (a
monoclonal antibody against GP64)-treated BV and immuno-
electron microscopy data, it was reported that direct fusion
with the cell surface is an alternative infection pathway of BV
in insect cells, although it is considered an inefficient infection
because it is thought to lead to the degradation of the virus
genome (45). In our experiments, we also showed that at nor-
mal pH even if there is any direct fusion, it would be unde-
FIG. 9. Schematic of two different entry pathways of AcMNPV in Sf9 cells. Pathway 1 indicates the classic endocytosis pathway. BV enter the
cells via clathrin-mediated endocytosis, and nucleocapsids are released from the endosomes and transported to the nucleus with the help of
myosin-like proteins. Pathway 2 indicates the hypothetical direct fusion pathway. Virus envelopes fuse with the cell membrane and release the
nucleocapsids into the cytoplasm when triggered by acidic conditions. The nucleocapsids then are transported to the nucleus with the help of
myosin-like proteins. Both pathways lead to successful infection in Sf9 cells. CCV, clathrin-coated vesicle; NCV, noncoated vesicle; EE, early
endosome; LE, late endosome; LYS, lysosome; NPC, nuclear pore complex; BAF1, bafilomycin A1.
VOL. 84, 2010 LOW pH TRIGGERS DIRECT FUSION ENTRY OF ACMNPV 5357
 at W
ageningen UR Library on M
ay 30, 2010 
jvi.asm.org
D
ow
nloaded from
 
tectable, since NH4Cl and CPZ could inhibit most of the in-
fection (Fig. 2). However, when the AcMNPV infection was
triggered with low pH, it resulted in a completely different
outcome that is definitely considered the result of a successful
infection in this particular circumstance.
For some viruses using the endocytosis pathway, the endo-
somal proteolysis is critical for viral infection. The endosomal
proteolysis of the glycoprotein is necessary for infection by
Ebola virus and SARS-CoV (3, 30, 38). Proteolysis by endo-
somal cathepsin L or B also is suggested to be a crucial medi-
ator for reovirus disassembly that led to the release of the
transcriptionally active virions in murine fibroblast cells (6).
Although baculoviruses normally use endocytosis to enter in-
sect and mammalian cells, it is suggested that the endocytic
modification of the nucleocapsids is not necessary for the bacu-
loviruses to travel to the nucleus in human hepatocytes. In
these experiments, the nonenveloped nucleocapsids were mi-
croinjected into HepG2 cells, and the localization of nucleo-
capsids then was monitored by immunolabeling. At 6 h p.i., the
stained nucleocapsids were observed in both the cytoplasm and
nucleus (35). In our experiment, acid treatment forced the
AcMNPV to fuse at the cell surface, releasing the nucleocap-
sids into the cytoplasm and finally enabling the productive
infection in Sf9 cells. Since the virions were released at the cell
surface and infected Sf9 cells through a nonendocytosis path-
way, it is likely that the modifications of the nucleocapsids in
the endosomes were not essential for the AcMNPV infection
in insect cells.
BV of AcMNPV can transduce many mammalian cells and
is considered a potential transduction vector for foreign gene
expression and gene therapy (19, 20). Although the baculovi-
rus-derived vector has emerged as an efficient gene transfer
vector in mammalian cells, the large amount of virus needed
for successful transduction imposed a restriction on the appli-
cation of this system. Recently, several baculoviruses with a
variety of different membrane attachment proteins were devel-
oped and showed an improvement of the transduction rate in
certain mammalian cells (7, 8, 17, 34). However, most of these
improvements require the modification of the baculoviruses,
and a simpler method is required. In our experiment, once the
entry pathway was modified with the acidic environment, a
great improvement in the transduction rate was observed in
both HepG2 and HeLa cells, even in the presence of NH4Cl
(Fig. 6). The great improvement of the transduction rate with
the simple modification of the entry pathway made it much
easier to transduce the mammalian cells, and a lower viral dose
was needed to reach the same transduction rate without any
gene modifications. However, whether this supplemental in-
fection pathway also could improve the transduction rate in
other mammalian cells or even expand the transduction range
remains to be investigated.
In conclusion, this study revealed that with a low-pH trigger,
BV of AcMNPV can infect insect cells by fusion at the cell
surface as efficiently as the clathrin-mediated endocytosis path-
way. This is the first demonstration of the existence of a second
efficient infection pathway in BV of AcMNPV. We found that
after fusion with the cell membrane, the myosin-like proteins
aid the transport of the nucleocapsids to the nucleus while the
intact microtubules are not necessary for this process. More
importantly, we found that a low-pH trigger could significantly
improve the transduction efficiency of AcMNPV in mamma-
lian cells, which implies the potential application of this
method when using baculovirus as a vector for heterologous
gene expression and for gene therapy.
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